Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Charlotte Hetzel

Dr Charlotte Hetzel
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Alice Nettleton

Alice Nettleton
Healthcare Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Andy Smith

Andy Smith
Analyst

Briana Warschun

Briana Warschun
Associate Healthcare Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Targovax ASLAN Pharmaceuticals
Cellular Biomedicine Group Sierra Oncology
Laboratorios Farmacéuticos ROVI Therapix Biosciences

Recent QuickViews

aap Implantate

Focus is the key foundation

Pharmaceutical & healthcare | published 28/11/2017
Heidelberg Pharma

ATACking cancer cells with novel technology

Pharmaceutical & healthcare | published 16/11/2017
CO.DON

Green light for Spherox from the EMA

Pharmaceutical & healthcare | published 15/11/2017
Smith & Nephew

No distractions from the search for growth

Pharmaceutical & healthcare | published 10/11/2017

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Massive fatty liver opportunity

Review | Pharmaceutical & healthcare | 15/12/2017

One Way Liver (OWL), a private company, sells a non-invasive sophisticated lab diagnostic (OWLiver) to detect liver inflammation. The obesity epidemic…

SymBio Pharmaceuticals

Licence agreement for IONSYS terminated

ADR Update | Pharmaceutical & healthcare | 15/12/2017

The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in Japan has…

NetScientific

Commercial progress across portfolio

Update | Pharmaceutical & healthcare | 15/12/2017

Within the month of November 2017, NetScientific portfolio companies had a series of announcements reflecting increased adoption of their products. ProAxsis…

NeuroVive Pharmaceutical

Two new trials and likely out-licensing in 2018

Update | Pharmaceutical & healthcare | 14/12/2017

NeuroVive has made progress on multiple fronts over the past few months with both its core asset portfolio and non-core projects for out-licensing. Notable…

SymBio Pharmaceuticals

Licence agreement for IONSYS terminated

Update | Pharmaceutical & healthcare | 14/12/2017

The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in Japan has…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies